BINDING SITE, INC., THE

BINDING SITE, INC., THE specializes in the manufacturing and supply of in-vitro diagnostic substances and analytical laboratory instrumentation for federal healthcare and defense missions. The company delivers critical reagents, test kits, and precision analyzers—including Optilite and FreeLight systems—used in clinical immunodiagnostic testing, special protein analysis, and infectious disease screening. Their technical expertise spans assay development, turbidimetric instrumentation, and cost-per-test reagent supply chains, with a demonstrated focus on FDA-regulated diagnostic products compliant with federal health protocols. A key differentiator is their ability to integrate diagnostic reagents with proprietary analyzers to enable high-throughput, point-of-care testing environments aligned with VA and HHS clinical workflows. The contractor maintains a deep, sustained relationship with the Department of Veterans Affairs, consistently providing diagnostic reagents, analyzer systems, and consumables to support veteran healthcare operations across VA medical centers. Work includes vaccine mandate compliance testing, specialty protein assays, and long-term supply agreements for laboratory diagnostics. Limited engagements with the Department of Health and Human Services and the Department of Defense further indicate alignment with public health emergency response and military medical readiness initiatives. Industry focus centers on NAICS 325413 (in-vitro diagnostic substance manufacturing) and 334516 (analytical laboratory instrument manufacturing), positioning BINDING SITE as a niche supplier of clinical diagnostics hardware and reagents. The company serves the federal biomedical testing market with specialized solutions for immunoassays, clinical chemistry, and rapid pathogen detection, distinguishing itself through tightly integrated instrument-reagent systems. BINDING SITE, INC., THE is a small business structured as a 2L entity, headquartered in San Diego, California. While no formal government certifications are listed, its consistent performance on federal contracts demonstrates operational reliability in regulated medical manufacturing environments. The company’s geographic proximity to federal biomedical research and procurement hubs enhances its responsiveness to agency needs.